WHO's emergency use authorisation for Covaxin further delayed: Sources

The sources further said that the UN public health agency has asked for more data from Bharat Biotech for Covaxin. This delay will affect Indians especially students and who have international travel plans. The EUA is important because without it Covaxin will not be accepted by most countries.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ob1qKQ
via IFTTT